Developing a new tool for analyzing cancer cells to improve treatment selection
Rapid, Single Cell Proteomic Profiling for Biomarker Development in Precision Oncology
This study is working on a new tool that looks closely at individual cancer cells to help doctors better understand which patients might benefit from the latest cancer treatments, making it easier for more clinics to use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aperture Bio, INC. NIH-funded |
| Lab location | 1 site (Allston, United States) |
| Project ID | NIH-10911716 on NIH RePORTER |
What this research studies
This research focuses on creating a novel diagnostic tool that can analyze cancer cells at a single-cell level, providing detailed information about protein expression and cell states. By utilizing advanced techniques that improve upon traditional methods, the project aims to enhance the accuracy of patient selection for next-generation cancer therapies. The goal is to develop a platform that can be used with standard laboratory equipment, making it accessible for broader clinical use. This approach seeks to address the significant challenges faced by oncologists in determining which patients are likely to benefit from specific treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are undergoing treatment and may benefit from more precise diagnostic tools.
Not a fit: Patients with cancers that are not amenable to the types of analysis being developed may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments by enabling better patient selection for therapies.
How similar studies have performed: Other research has shown promise in developing advanced diagnostic tools for cancer, but this specific approach is relatively novel.
Where this research is happening
Allston, United States
- Aperture Bio, INC. — Allston, United States (Active)
Researchers
- Principal investigator: Peterson, Hannah Marie — Aperture Bio, INC.
- Study coordinator: Peterson, Hannah Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.